XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Expense
The following stock-based compensation expense was recognized for the periods indicated (in thousands):
Three Months Ended March 31,
20252024
Research and development$3,083 $2,829 
Selling, general and administrative1,303 2,724 
Total stock-based compensation expense$4,386 $5,553 
Valuation Assumptions Using the Black-Scholes Option-Pricing Model
The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model using the assumptions in the following table for options issued during the period indicated:
Three Months Ended March 31,
20252024
Expected dividend yield0%0%
Expected volatility
110.7% -115.6%
94.9% - 95.5%
Risk-free interest rate
4.0% - 4.5%
4.0% - 4.4%
Expected term6.11 years6.06 years
Schedule of Stock Options Roll Forward
The following table summarizes stock option activity during the three months ended March 31, 2025:
SharesWeighted-
Average
Exercise Price
Weighted-Average
Remaining
Contractual Term
(Years)
Aggregate
Intrinsic
Value
 (in thousands)
Outstanding, December 31, 202412,939,517 $14.80 6.4
Granted1,760,870 2.58 
Exercised— — 
Forfeited(203,736)9.97 
Expired(28,644)19.11 
Outstanding, March 31, 202514,468,007 $13.37 6.6$— 
As of March 31, 2025:
Exercisable9,730,401 $16.20 5.5$— 
Vested and expected to vest14,081,415 $13.52 6.5$— 
Schedule of RSU Activity
The following table summarizes RSU activity during the three months ended March 31, 2025:
Shares
Weighted-Average
Grant Date Fair Value
Outstanding, December 31, 20241,068,994 $11.97 
Granted315,670 2.60 
Vested(379,817)11.40 
Forfeited(49,198)12.04 
Outstanding, March 31, 2025955,649 $9.10 
Stock Option Additional Information [Table] The following table summarizes additional information on stock options (in thousands, except per
share amounts):
Three Months Ended March 31,
20252024
Weighted-average fair value per share of stock options granted
$2.23 $14.17 
Total intrinsic value of stock options exercised
$— $1,918 
Total cash received for stock options exercised
$— $2,636 
Total grant date fair value of stock options vested
$6,118 $3,903